Work

Venous Vascular Closure System Versus Conventional Figure of Eight Suture Following Single Shot Device Pulmonary Vein Isolation: The VASC-AF Study

Year: 2026
Type: article
Abstract: AIMS: Optimization of femoral venous access management has become increasingly important as catheter ablation of atrial fibrillation (AF) continues to evolve towards greater safety with accelerated recovery pathways. We evaluated the efficacy and safety of a bioabsorbable venous vascular closure system (VCS) compared with a conventional figure-of-eight (F8) suture and manual compression following contemporary single-shot pulmonary vein isolation (PVI). METHODS AND RESULTS: VASC-AF was a prospective, multicentre, randomized controlled trial performed at three German electrophysiology centres. One hundred consecutive patients undergoing single-shot PVI were randomized in a 1:1 ratio to femoral venous closure using the VASCADE MVP VCS; (n=50) or conventional F8 suture (n=50). The primary efficacy endpoint was time to ambulation. The primary safety endpoint comprised major periprocedural adverse events requiring medical intervention before hospital discharge.Baseline characteristics and procedural variables were comparable between study groups. Median time to ambulation was significantly shorter following vascular closure with VCS compared with F8 sutures (120 [120-150] vs. 180 [180-240] min; P=0.015). Likewise, time to haemostasis (0.5 [0.5-2] vs. 1 [1-2] min; P=0.021) and time to discharge eligibility (2.5 [2.1-3.0] vs. 4.0 [3.0-5.0] h; P=0.019) were significantly reduced.Major adverse events occurred infrequently and did not differ significantly between groups. In contrast, vascular closure using VCS significantly reduced minor vascular access complications (6% vs. 26%; P=0.006), groin pain, and patient discomfort while improving overall post-procedural satisfaction. CONCLUSION: Among patients undergoing contemporary single-shot AF ablation, use of a bioabsorbable VCS significantly accelerated post-procedural recovery while maintaining a comparable major safety profile. Reduced access-site complications and improved patient-reported outcomes support VCS as an important component of enhanced recovery pathways following AF ablation especially in an ambulatory or Same-Day Discharge setting.
Source: EP Europace
Language: English
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $4,909
OpenAlex ID: W7235870274
FWCI:
Cites: 30
Cited by:
Related to: 10